학술논문
Mitral Valve in Obstructive Hypertrophic Cardiomyopathy: Abnormalities, Management and Controversies
Document Type
article
Author
Source
Reviews in Cardiovascular Medicine, Vol 24, Iss 9, p 246 (2023)
Subject
Language
English
ISSN
1530-6550
Abstract
Obstructive hypertrophic cardiomyopathy (obstructive HCM) is a hereditary disease characterized by septal hypertrophy and dynamic left ventricular outflow tract (LVOT) obstruction. Other than septal hypertrophy, mitral valve abnormalities are also quite common in patients with obstructive HCM, which may contribute to systolic anterior motion (SAM) of the mitral valve and LVOT obstruction. Surgical myectomy is the standard treatment to achieve anatomic correction of obstructive HCM, but controversies remain on whether and how the mitral valve procedures should be performed at the same time. In this review, we first described the mitral valve abnormalities in patients with obstructive HCM and their surgical corrections, we then explained the controversies based on current clinical studies, and we finally made a brief introduction on our surgical strategy and results.